CONCETTA POIDOMANI: Open Payments
NPI 1689924482 · PHOENIXVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$733 in 17 payments from 9 companies in 2025. Trend: 2023 $519 · 2024 $481 · 2025 $733
Food & beverage: $733
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $113 |
| Boston Scientific Corporation | 1 | $113 |
| Novo Nordisk Inc | 1 | $100 |
| Mallinckrodt Hospital Products Inc. | 1 | $100 |
| Lilly USA, LLC | 1 | $99 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $90 |
| Exeltis, USA Inc. | 4 | $76 |
| Sage Therapeutics, LLC | 1 | $22 |
| Evofem Biosciences, Inc. | 1 | $20 |
Products named: Advantage System, ACTHAR, ZEPBOUND, SLYND, ZURZUVAE, Phexxi.
Industry payments across PA — which companies pay providers there.
